Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter to the Editor re: "Children with enuresis - are they more constipated than others?"

Journal of pediatric urology·2026
Same author

Response to Letter to the Editor re: "Children with enuresis - are they more constipated than others?"

Journal of pediatric urology·2026
Same author

Children with enuresis - are they more constipated than others?

Journal of pediatric urology·2026
Same author

Lower urinary tract symptoms in adults treated for vesico-ureteral reflux in childhood, compared to healthy controls.

Scandinavian journal of urology·2026
Same author

School Nurses' Experiences of the School-Based HPV Vaccination Program - A Decade Later.

The Journal of school nursing : the official publication of the National Association of School Nurses·2025
Same author

Improving the efficacy of enuresis alarm treatment through early prediction of treatment outcome: a machine learning approach.

Frontiers in urology·2025

Related Experiment Video

Updated: May 17, 2026

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
06:37

An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

Published on: April 4, 2025

Can postpyelonephritic renal scarring be prevented?

Tryggve Nevéus

    Pediatric Nephrology (Berlin, Germany)
    |October 23, 2012
    PubMed
    Summary

    Childhood pyelonephritis can cause kidney scarring and future heart problems. Antioxidant therapy with vitamins A or E may reduce this scarring in children, warranting further research.

    Area of Science:

    • Pediatric Nephrology
    • Renal Scarring Pathophysiology
    • Antioxidant Therapy Mechanisms

    Background:

    • Childhood pyelonephritis poses a risk for long-term cardiovascular morbidity secondary to tubulointerstitial renal scarring.
    • Renal damage results from complex interactions involving urinary tract factors, bacterial virulence, and host immune responses.
    • The prevalence of post-pyelonephritic scarring versus congenital renal hypoplasia remains unclear, though certain risk factors are identified.

    Discussion:

    • The study investigates the potential of antioxidant therapy (Vitamins A and E) as an adjunct to antibiotics in mitigating renal scarring post-pyelonephritis.
    • While animal studies suggest anti-inflammatory/antioxidant approaches may be beneficial, human research has been limited.
    • The findings suggest a promising therapeutic avenue for preventing long-term renal damage in children.

    More Related Videos

    Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
    04:37

    Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

    Published on: April 25, 2025

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    Related Experiment Videos

    Last Updated: May 17, 2026

    An Immature Murine Model of Reversible Unilateral Ureteral Obstruction
    06:37

    An Immature Murine Model of Reversible Unilateral Ureteral Obstruction

    Published on: April 4, 2025

    Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
    04:37

    Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

    Published on: April 25, 2025

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
    05:34

    5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

    Published on: April 4, 2025

    Key Insights:

    • Antioxidant therapy with vitamins A or E may reduce the risk of renal scarring in children diagnosed with pyelonephritis.
    • Identifying high-risk cases, such as those with significant renal scintigraphy defects or dilating vesicoureteral reflux, is crucial.
    • This study provides initial human evidence supporting the use of antioxidants in managing pyelonephritis complications.

    Outlook:

    • Further clinical trials are essential to validate the efficacy and optimal use of antioxidant therapy in preventing renal scarring.
    • Exploring the precise molecular mechanisms underlying antioxidant protection in pyelonephritis is a key future direction.
    • This research opens avenues for novel therapeutic strategies to improve long-term renal and cardiovascular health in affected children.